1
|
Caldarella C, De Risi M, Massaccesi M, Miccichè F, Bussu F, Galli J, Rufini V, Leccisotti L. Role of 18F-FDG PET/CT in Head and Neck Squamous Cell Carcinoma: Current Evidence and Innovative Applications. Cancers (Basel) 2024; 16:1905. [PMID: 38791983 PMCID: PMC11119768 DOI: 10.3390/cancers16101905] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2024] [Revised: 05/08/2024] [Accepted: 05/13/2024] [Indexed: 05/26/2024] Open
Abstract
This article provides an overview of the use of 18F-FDG PET/CT in various clinical scenarios of head-neck squamous cell carcinoma, ranging from initial staging to treatment-response assessment, and post-therapy follow-up, with a focus on the current evidence, debated issues, and innovative applications. Methodological aspects and the most frequent pitfalls in head-neck imaging interpretation are described. In the initial work-up, 18F-FDG PET/CT is recommended in patients with metastatic cervical lymphadenectomy and occult primary tumor; moreover, it is a well-established imaging tool for detecting cervical nodal involvement, distant metastases, and synchronous primary tumors. Various 18F-FDG pre-treatment parameters show prognostic value in terms of disease progression and overall survival. In this scenario, an emerging role is played by radiomics and machine learning. For radiation-treatment planning, 18F-FDG PET/CT provides an accurate delineation of target volumes and treatment adaptation. Due to its high negative predictive value, 18F-FDG PET/CT, performed at least 12 weeks after the completion of chemoradiotherapy, can prevent unnecessary neck dissections. In addition to radiomics and machine learning, emerging applications include PET/MRI, which combines the high soft-tissue contrast of MRI with the metabolic information of PET, and the use of PET radiopharmaceuticals other than 18F-FDG, which can answer specific clinical needs.
Collapse
Affiliation(s)
- Carmelo Caldarella
- Nuclear Medicine Unit, Department of Radiology and Oncologic Radiotherapy, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy; (C.C.); (M.D.R.); (L.L.)
| | - Marina De Risi
- Nuclear Medicine Unit, Department of Radiology and Oncologic Radiotherapy, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy; (C.C.); (M.D.R.); (L.L.)
| | - Mariangela Massaccesi
- Radiation Oncology Unit, Department of Radiology and Oncologic Radiotherapy, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy;
| | - Francesco Miccichè
- Radiation Oncology Unit, Ospedale Isola Tiberina—Gemelli Isola, 00186 Rome, Italy;
| | - Francesco Bussu
- Otorhinolaryngology Operative Unit, Azienda Ospedaliero Universitaria Sassari, 07100 Sassari, Italy;
- Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy
| | - Jacopo Galli
- Otorhinolaryngology Unit, Department of Neurosciences, Sensory Organs and Thorax, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy;
- Section of Otolaryngology, Department of Head-Neck and Sensory Organs, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
| | - Vittoria Rufini
- Nuclear Medicine Unit, Department of Radiology and Oncologic Radiotherapy, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy; (C.C.); (M.D.R.); (L.L.)
- Section of Nuclear Medicine, Department of Radiological Sciences and Hematology, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
| | - Lucia Leccisotti
- Nuclear Medicine Unit, Department of Radiology and Oncologic Radiotherapy, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy; (C.C.); (M.D.R.); (L.L.)
- Section of Nuclear Medicine, Department of Radiological Sciences and Hematology, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
| |
Collapse
|
2
|
Early Monitoring Response to Therapy in Patients with Brain Lesions Using the Cumulative SUV Histogram. APPLIED SCIENCES-BASEL 2021. [DOI: 10.3390/app11072999] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Gamma Knife treatment is an alternative to traditional brain surgery and whole-brain radiation therapy for treating cancers that are inaccessible via conventional treatments. To assess the effectiveness of Gamma Knife treatments, functional imaging can play a crucial role. The aim of this study is to evaluate new prognostic indices to perform an early assessment of treatment response to therapy using positron emission tomography imaging. The parameters currently used in nuclear medicine assessments can be affected by statistical fluctuation errors and/or cannot provide information on tumor extension and heterogeneity. To overcome these limitations, the Cumulative standardized uptake value (SUV) Histogram (CSH) and Area Under the Curve (AUC) indices were evaluated to obtain additional information on treatment response. For this purpose, the absolute level of [11C]-Methionine (MET) uptake was measured and its heterogeneity distribution within lesions was evaluated by calculating the CSH and AUC indices. CSH and AUC parameters show good agreement with patient outcomes after Gamma Knife treatments. Furthermore, no relevant correlations were found between CSH and AUC indices and those usually used in the nuclear medicine environment. CSH and AUC indices could be a useful tool for assessing patient responses to therapy.
Collapse
|
3
|
Comelli A. Fully 3D Active Surface with Machine Learning for PET Image Segmentation. J Imaging 2020; 6:jimaging6110113. [PMID: 34460557 PMCID: PMC8321170 DOI: 10.3390/jimaging6110113] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2020] [Revised: 10/16/2020] [Accepted: 10/20/2020] [Indexed: 12/12/2022] Open
Abstract
In order to tackle three-dimensional tumor volume reconstruction from Positron Emission Tomography (PET) images, most of the existing algorithms rely on the segmentation of independent PET slices. To exploit cross-slice information, typically overlooked in these 2D implementations, I present an algorithm capable of achieving the volume reconstruction directly in 3D, by leveraging an active surface algorithm. The evolution of such surface performs the segmentation of the whole stack of slices simultaneously and can handle changes in topology. Furthermore, no artificial stop condition is required, as the active surface will naturally converge to a stable topology. In addition, I include a machine learning component to enhance the accuracy of the segmentation process. The latter consists of a forcing term based on classification results from a discriminant analysis algorithm, which is included directly in the mathematical formulation of the energy function driving surface evolution. It is worth noting that the training of such a component requires minimal data compared to more involved deep learning methods. Only eight patients (i.e., two lung, four head and neck, and two brain cancers) were used for training and testing the machine learning component, while fifty patients (i.e., 10 lung, 25 head and neck, and 15 brain cancers) were used to test the full 3D reconstruction algorithm. Performance evaluation is based on the same dataset of patients discussed in my previous work, where the segmentation was performed using the 2D active contour. The results confirm that the active surface algorithm is superior to the active contour algorithm, outperforming the earlier approach on all the investigated anatomical districts with a dice similarity coefficient of 90.47 ± 2.36% for lung cancer, 88.30 ± 2.89% for head and neck cancer, and 90.29 ± 2.52% for brain cancer. Based on the reported results, it can be claimed that the migration into a 3D system yielded a practical benefit justifying the effort to rewrite an existing 2D system for PET imaging segmentation.
Collapse
|
4
|
Stefano A, Comelli A, Bravatà V, Barone S, Daskalovski I, Savoca G, Sabini MG, Ippolito M, Russo G. A preliminary PET radiomics study of brain metastases using a fully automatic segmentation method. BMC Bioinformatics 2020; 21:325. [PMID: 32938360 PMCID: PMC7493376 DOI: 10.1186/s12859-020-03647-7] [Citation(s) in RCA: 26] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2020] [Accepted: 07/09/2020] [Indexed: 12/20/2022] Open
Abstract
Background Positron Emission Tomography (PET) is increasingly utilized in radiomics studies for treatment evaluation purposes. Nevertheless, lesion volume identification in PET images is a critical and still challenging step in the process of radiomics, due to the low spatial resolution and high noise level of PET images. Currently, the biological target volume (BTV) is manually contoured by nuclear physicians, with a time expensive and operator-dependent procedure. This study aims to obtain BTVs from cerebral metastases in patients who underwent L-[11C]methionine (11C-MET) PET, using a fully automatic procedure and to use these BTVs to extract radiomics features to stratify between patients who respond to treatment or not. For these purposes, 31 brain metastases, for predictive evaluation, and 25 ones, for follow-up evaluation after treatment, were delineated using the proposed method. Successively, 11C-MET PET studies and related volumetric segmentations were used to extract 108 features to investigate the potential application of radiomics analysis in patients with brain metastases. A novel statistical system has been implemented for feature reduction and selection, while discriminant analysis was used as a method for feature classification. Results For predictive evaluation, 3 features (asphericity, low-intensity run emphasis, and complexity) were able to discriminate between responder and non-responder patients, after feature reduction and selection. Best performance in patient discrimination was obtained using the combination of the three selected features (sensitivity 81.23%, specificity 73.97%, and accuracy 78.27%) compared to the use of all features. Secondly, for follow-up evaluation, 8 features (SUVmean, SULpeak, SUVmin, SULpeak prod-surface-area, SUVmean prod-sphericity, surface mean SUV 3, SULpeak prod-sphericity, and second angular moment) were selected with optimal performance in discriminant analysis classification (sensitivity 86.28%, specificity 87.75%, and accuracy 86.57%) outperforming the use of all features. Conclusions The proposed system is able i) to extract 108 features for each automatically segmented lesion and ii) to select a sub-panel of 11C-MET PET features (3 and 8 in the case of predictive and follow-up evaluation), with valuable association with patient outcome. We believe that our model can be useful to improve treatment response and prognosis evaluation, potentially allowing the personalization of cancer treatment plans.
Collapse
Affiliation(s)
- Alessandro Stefano
- Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Cefalù, Italy
| | - Albert Comelli
- Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Cefalù, Italy.,Ri.MED Foundation, Palermo, Italy
| | - Valentina Bravatà
- Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Cefalù, Italy.
| | | | - Igor Daskalovski
- Department of Physics and Astronomy, University of Catania, Catania, Italy
| | - Gaetano Savoca
- Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Cefalù, Italy
| | | | - Massimo Ippolito
- Nuclear Medicine Department, Cannizzaro Hospital, Catania, Italy
| | - Giorgio Russo
- Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Cefalù, Italy.,Medical Physics Unit, Cannizzaro Hospital, Catania, Italy
| |
Collapse
|
5
|
Comelli A, Bignardi S, Stefano A, Russo G, Sabini MG, Ippolito M, Yezzi A. Development of a new fully three-dimensional methodology for tumours delineation in functional images. Comput Biol Med 2020; 120:103701. [PMID: 32217282 PMCID: PMC7237290 DOI: 10.1016/j.compbiomed.2020.103701] [Citation(s) in RCA: 25] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2019] [Revised: 03/11/2020] [Accepted: 03/11/2020] [Indexed: 01/15/2023]
Abstract
Delineation of tumours in Positron Emission Tomography (PET) plays a crucial role in accurate diagnosis and radiotherapy treatment planning. In this context, it is of outmost importance to devise efficient and operator-independent segmentation algorithms capable of reconstructing the tumour three-dimensional (3D) shape. In previous work, we proposed a system for 3D tumour delineation on PET data (expressed in terms of Standardized Uptake Value - SUV), based on a two-step approach. Step 1 identified the slice enclosing the maximum SUV and generated a rough contour surrounding it. Such contour was then used to initialize step 2, where the 3D shape of the tumour was obtained by separately segmenting 2D PET slices, leveraging the slice-by-slice marching approach. Additionally, we combined active contours and machine learning components to improve performance. Despite its success, the slice marching approach poses unnecessary limitations that are naturally removed by performing the segmentation directly in 3D. In this paper, we migrate our system into 3D. In particular, the segmentation in step 2 is now performed by evolving an active surface directly in the 3D space. The key points of such an advancement are that it performs the shape reconstruction on the whole stack of slices simultaneously, naturally leveraging cross-slice information that could not be exploited before. Additionally, it does not require any specific stopping condition, as the active surface naturally reaches a stable topology once convergence is achieved. Performance of this fully 3D approach is evaluated on the same dataset discussed in our previous work, which comprises fifty PET scans of lung, head and neck, and brain tumours. The results have confirmed that a benefit is indeed achieved in practice for all investigated anatomical districts, both quantitatively, through a set of commonly used quality indicators (dice similarity coefficient >87.66%, Hausdorff distance < 1.48 voxel and Mahalanobis distance < 0.82 voxel), and qualitatively in terms of Likert score (>3 in 54% of the tumours).
Collapse
Affiliation(s)
- Albert Comelli
- Ri.MED Foundation, via Bandiera 11, 90133, Palermo, Italy
| | - Samuel Bignardi
- Department of Electrical and Computer Engineering, Georgia Institute of Technology, Atlanta, GA, 30332, USA
| | - Alessandro Stefano
- Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Cefalù, Italy.
| | - Giorgio Russo
- Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Cefalù, Italy; Medical Physics Unit, Cannizzaro Hospital, Catania, Italy
| | | | - Massimo Ippolito
- Nuclear Medicine Department, Cannizzaro Hospital, Catania, Italy
| | - Anthony Yezzi
- Department of Electrical and Computer Engineering, Georgia Institute of Technology, Atlanta, GA, 30332, USA
| |
Collapse
|